Published in J Addict Res Ther on November 15, 2011
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. J Addict Res Ther (2012) 1.19
Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration. Neuropharmacology (2012) 0.97
Positive Allosteric Modulation of mGluR5 Accelerates Extinction Learning but Not Relearning Following Methamphetamine Self-Administration. Front Pharmacol (2012) 0.88
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacol Rev (2015) 0.88
Methamphetamine self-administration in mice decreases GIRK channel-mediated currents in midbrain dopamine neurons. Int J Neuropsychopharmacol (2014) 0.86
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18
Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA (2000) 14.17
Meta-analysis of cue-reactivity in addiction research. Addiction (1999) 10.43
The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) (2002) 9.90
The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci (2009) 5.97
New uses for old drugs. Nature (2007) 5.86
Transition from moderate to excessive drug intake: change in hedonic set point. Science (1998) 5.66
Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol (2005) 5.13
Cellular and molecular mechanisms of drug dependence. Science (1988) 4.99
Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry (2000) 4.87
A role for brain stress systems in addiction. Neuron (2008) 4.71
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry (2007) 4.37
Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev (2002) 4.23
Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) (2006) 4.23
Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol (2006) 3.94
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev (2000) 3.40
New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol (2007) 3.23
Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol Clin Exp Res (2004) 3.19
Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology (2000) 3.15
Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci (2001) 3.09
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Horm Behav (2006) 3.02
Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry (2004) 3.02
Review. Context-induced relapse to drug seeking: a review. Philos Trans R Soc Lond B Biol Sci (2008) 2.98
Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev (2004) 2.97
Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci (2002) 2.83
Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci (2006) 2.74
Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci (2002) 2.69
Methamphetamine use behaviors and gender differences. Addict Behav (2004) 2.67
A cannabinoid mechanism in relapse to cocaine seeking. Nat Med (2001) 2.65
The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol Psychiatry (2004) 2.41
Animal models of drug craving. Psychopharmacology (Berl) (1993) 2.32
Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology (Berl) (2006) 2.24
Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr (1993) 2.23
Glutamate transmission in addiction. Neuropharmacology (2008) 2.19
Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry (2001) 2.14
The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology (Berl) (2003) 2.13
Lobeline attenuates d-methamphetamine self-administration in rats. J Pharmacol Exp Ther (2001) 2.08
The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) (2000) 2.06
Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav (2005) 2.05
Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology (2000) 2.04
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction (2009) 2.03
A systematic review of modafinil: Potential clinical uses and mechanisms of action. J Clin Psychiatry (2006) 2.03
Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci U S A (2000) 2.01
Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse (1996) 1.97
Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry (2005) 1.94
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci (1995) 1.91
The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci (1998) 1.91
A population-based study of cigarette smoking among illicit drug users in the United States. Addiction (2002) 1.91
A cognitive processing model of alcohol craving and compulsive alcohol use. Addiction (2000) 1.90
Cocaine-induced cocaine craving. Psychopharmacology (Berl) (1989) 1.88
Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking. Neuropsychopharmacology (2006) 1.84
Medication development for addictive disorders: the state of the science. Am J Psychiatry (2005) 1.83
mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology (2004) 1.83
Gender differences in methamphetamine use and responses: a review. Gend Med (2008) 1.83
Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology (Berl) (2005) 1.82
Lobelane decreases methamphetamine self-administration in rats. Eur J Pharmacol (2007) 1.82
Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend (2009) 1.77
Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse (1996) 1.75
Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking. Behav Brain Res (2009) 1.73
Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol (2010) 1.71
Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res (1980) 1.70
Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology (1999) 1.69
Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci (1994) 1.68
Challenges in the manipulation, assessment and interpretation of craving relevant variables. Addiction (2000) 1.66
Lobeline does not serve as a reinforcer in rats. Psychopharmacology (Berl) (2002) 1.63
Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Biol Psychiatry (2010) 1.63
Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology (2004) 1.62
Modulation of D2R-NR2B interactions in response to cocaine. Neuron (2006) 1.62
Neural responses to acute cocaine administration in the human brain detected by fMRI. Neuroimage (2005) 1.59
Glutamate and reinstatement. Curr Opin Pharmacol (2009) 1.59
mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats. Neuropsychopharmacology (2008) 1.57
Suppression of methamphetamine-seeking behavior by nicotinic agonists. Proc Natl Acad Sci U S A (2006) 1.56
Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther (2000) 1.56
Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry (2011) 1.53
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend (2003) 1.50
Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology (2002) 1.50
Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res (1989) 1.48
Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev (2008) 1.48
Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend (2006) 1.47
Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin Investig Drugs (2007) 1.45
Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther (2009) 1.43
The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology (Berl) (2003) 1.43
Patterns of methamphetamine abuse and their consequences. J Addict Dis (2002) 1.42
Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior. Pavlov J Biol Sci (1977) 1.38
Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology (Berl) (2008) 1.38
Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacology (2007) 1.38
Context and ambiguity in the extinction of emotional learning: implications for exposure therapy. Behav Res Ther (1988) 1.37
Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer. J Pharmacol Exp Ther (2009) 1.36
CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology (Berl) (2007) 1.35
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology (Berl) (2001) 1.34
High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J Neurosci (2004) 1.33
Naltrexone and relapse prevention treatment for cocaine-dependent patients. Addict Behav (2001) 1.33
Conceptual, methodological, and analytical issues in the study of relapse. Clin Psychol Rev (2005) 1.30
Unlimited access to heroin self-administration: independent motivational markers of opiate dependence. Neuropsychopharmacology (2006) 1.29
From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? Br J Pharmacol (2008) 1.28
Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology (2004) 1.27
What we have learned about addiction from animal models of drug self-administration. Am J Addict (2000) 1.27
N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci (2009) 3.49
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis. Nat Med (2010) 1.84
mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology (2009) 1.80
Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol (2012) 1.64
mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats. Neuropsychopharmacology (2008) 1.57
Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory. Biol Psychiatry (2008) 1.43
The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse (2003) 1.41
Ethanol facilitates glutamatergic transmission to dopamine neurons in the ventral tegmental area. Neuropsychopharmacology (2008) 1.32
Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J Clin Invest (2002) 1.31
Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology (2010) 1.25
Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl) (2006) 1.24
Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol Clin Exp Res (2009) 1.13
Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models. J Neurosci (2012) 1.13
Role of protein kinase C epsilon (PKCvarepsilon) in the reduction of ethanol reinforcement due to mGluR5 antagonism in the nucleus accumbens shell. Psychopharmacology (Berl) (2009) 1.11
The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts" J Addict Res Ther (2012) 1.10
mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration. Behav Neurosci (2011) 1.10
The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions. Psychoneuroendocrinology (2004) 1.06
mGluR5 receptors in the basolateral amygdala and nucleus accumbens regulate cue-induced reinstatement of ethanol-seeking behavior. Pharmacol Biochem Behav (2012) 1.05
The Effects of Maternal Separation on Adult Methamphetamine Self-Administration, Extinction, Reinstatement, and MeCP2 Immunoreactivity in the Nucleus Accumbens. Front Psychiatry (2013) 1.03
Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors. Addict Biol (2010) 1.02
Reinstatement of ethanol-seeking behavior following intravenous self-administration in Wistar rats. Alcohol Clin Exp Res (2007) 1.01
Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders. Molecules (2011) 0.99
Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration. Neuropharmacology (2012) 0.97
A role for mGluR5 receptors in intravenous methamphetamine self-administration. Ann N Y Acad Sci (2008) 0.95
The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine. Br J Pharmacol (2003) 0.92
Attenuation of reinstatement of methamphetamine-, sucrose-, and food-seeking behavior in rats by fenobam, a metabotropic glutamate receptor 5 negative allosteric modulator. Psychopharmacology (Berl) (2012) 0.92
Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice. Psychopharmacology (Berl) (2004) 0.92
Effects of adolescent exposure to cocaine on locomotor activity and extracellular dopamine and glutamate levels in nucleus accumbens of DBA/2J mice. Brain Res (2007) 0.88
Positive Allosteric Modulation of mGluR5 Accelerates Extinction Learning but Not Relearning Following Methamphetamine Self-Administration. Front Pharmacol (2012) 0.88
The corticotropin-releasing factor/urocortin system and alcohol. Alcohol Clin Exp Res (2002) 0.88
Pharmacotherapies for alcoholism: the old and the new. CNS Neurol Disord Drug Targets (2010) 0.87
The mGluR5 Positive Allosteric Modulator CDPPB Does Not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats. J Addict Res Ther (2011) 0.87
Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology (Berl) (2007) 0.86
Role of the endogenous opioid system on the neuropsychopharmacological effects of ethanol: new insights about an old question. Alcohol Clin Exp Res (2005) 0.86
Safety and efficacy of acamprosate for the treatment of alcohol dependence. Subst Abuse (2013) 0.86
The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice. Expert Opin Drug Saf (2008) 0.85
Ethanol consumption patterns and conditioned place preference in mice lacking preproenkephalin. Neurosci Lett (2002) 0.85
Changes in extracellular levels of glutamate in the nucleus accumbens after ethanol-induced behavioral sensitization in adolescent and adult mice. Alcohol (2011) 0.83
mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task. Psychopharmacology (Berl) (2014) 0.82
Similar ethanol drinking in adolescent and adult C57BL/6J mice after chronic ethanol exposure and withdrawal. Alcohol Clin Exp Res (2013) 0.81
Intracranial stereotaxic cannulation for development of orthotopic glioblastoma allograft in Sprague-Dawley rats and histoimmunopathological characterization of the brain tumor. Neurochem Res (2007) 0.80
Constitutive knockout of kalirin-7 leads to increased rates of cocaine self-administration. Mol Pharmacol (2013) 0.80
Differential Modulation of Thresholds for Intracranial Self-Stimulation by mGlu5 Positive and Negative Allosteric Modulators: Implications for Effects on Drug Self-Administration. Front Pharmacol (2012) 0.80
Neurochemical and neurostructural plasticity in alcoholism. ACS Chem Neurosci (2012) 0.79
Ethanol pre-exposure during adolescence or adulthood increases ethanol intake but ethanol-induced conditioned place preference is enhanced only when pre-exposure occurs in adolescence. Dev Psychobiol (2012) 0.79
Early life stress and chronic variable stress in adulthood interact to influence methamphetamine self-administration in male rats. Behav Pharmacol (2016) 0.79
Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model. J Neurovirol (2014) 0.79
NMDA Receptor Modulators in the Treatment of Drug Addiction. Pharmaceuticals (Basel) (2013) 0.77
Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP. Eur J Pharmacol (2008) 0.77
Early-life stress interactions with the epigenome: potential mechanisms driving vulnerability toward psychiatric illness. Behav Pharmacol (2014) 0.77
Increases in doublecortin immunoreactivity in the dentate gyrus following extinction of heroin-seeking behavior. Neural Plast (2012) 0.77
Neuropeptide systems and schizophrenia. CNS Neurol Disord Drug Targets (2013) 0.76
mGlu receptors and drug addiction. Wiley Interdiscip Rev Membr Transp Signal (2012) 0.76
A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration. Addict Biol (2008) 0.76
The development of acamprosate as a treatment against alcohol relapse. Expert Opin Drug Discov (2014) 0.76
Extinction learning and adult neurogenesis. Neuropsychopharmacology (2011) 0.75
The effect of litter separation on methamphetamine-conditioned place preference in post-partum dams. Behav Pharmacol (2017) 0.75